Nordic Life Science cares about your privacy

The Nordic life science sector is losing highly qualified female talent in top leadership positions, according to a new white paper published by Women in Life Science Denmark (WiLD), WiLD Norway, and VILDA Sweden.

The research collaboration aims to develop a blood‑based test that measures naturally occurring antibodies against toxic amyloid‑β oligomers in healthy individuals, based on Alzinova’s Aβ42CC oligomer technology.

Thor Medical has entered into a multiyear frame agreement with Node Pharma for the supply of radium-224 and lead-212 for preclinical use.

The initiative comes from a group of private entrepreneurs in close collaboration with Business Region Gothenburg, Business Sweden, Swedish industries and NVIDIA as a technology partner.

A large-scale Nordic collaboration has developed the research on personalized pharmaceuticals and led to researcher training and mobility, new patient-oriented products, new technologies and startups.

The last two years include a new regional policy charter and dedicated Nordic women's health innovation hub introduced in our region.

In a region celebrated for gender equality, the life science sector tells a different story: women dominate the workforce in many jobs yet remain sidelined in leadership, funding, and research – with consequences that ripple across public health and economic performance.